DaVita Inc.
General ticker "DVA" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $11.1B (TTM average)
DaVita Inc. does not follow the US Stock Market performance with the rate: -19.2%.
Estimated limits based on current volatility of 2.3%: low 102.01$, high 106.74$
Factors to consider:
- Company included in S&P500 list
- Total employees count: 76000 as of 2024
- Top business risk factors: Supply chain disruptions, Technological changes, Geopolitical risks, ESG risks, IT system failures
- Current price 22.9% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [132.50$, 183.12$]
- 2025-12-31 to 2026-12-31 estimated range: [135.83$, 189.63$]
Financial Metrics affecting the DVA estimates:
- Negative: with PPE of 15.8 at the end of fiscal year the price was high
- Positive: 7.54 < Operating profit margin, % of 16.14
- Positive: Operating cash flow per share per price, % of 15.70 > 12.91
- Positive: -0.04 < Industry operating cash flow per share per price (median), % of 3.20
- Positive: Return on assets ratio (scaled to [-100,100]) of 6.75 > 6.04
- Negative: Shareholder equity ratio, % of 0.70 <= 19.35
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term DVA quotes
Relationship graph
Long-term DVA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $11,636.41MM | $12,168.01MM | $12,951.20MM |
| Operating Expenses | $10,297.35MM | $10,565.23MM | $10,860.72MM |
| Operating Income | $1,339.06MM | $1,602.78MM | $2,090.48MM |
| Non-Operating Income | $-372.78MM | $-425.69MM | $-560.09MM |
| Interest Expense | $357.02MM | $398.55MM | $470.47MM |
| Income(Loss) | $966.28MM | $1,177.09MM | $1,530.39MM |
| Taxes | $198.09MM | $220.12MM | $279.66MM |
| Other Income(Loss) | $13.45MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $560.40MM | $691.53MM | $936.34MM |
| Stockholders Equity | $712.33MM | $1,056.10MM | $121.12MM |
| Inventory | $109.12MM | $143.10MM | $134.56MM |
| Assets | $16,928.25MM | $16,893.58MM | $17,285.27MM |
| Operating Cash Flow | $1,564.57MM | $2,059.03MM | $2,022.04MM |
| Capital expenditure | $603.43MM | $567.99MM | $555.44MM |
| Investing Cash Flow | $-630.35MM | $-771.80MM | $-771.43MM |
| Financing Cash Flow | $-1,121.13MM | $-1,170.49MM | $-816.94MM |
| Earnings Per Share** | $6.03 | $7.62 | $11.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.